Clinical Trial Update: Evaluating New Formulation of Therapeutic HSV-2 Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a new formulation of a therapeutic vaccine for genital herpes caused by HSV-2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes Simplex Virus Type 2 Infection

Drugs mentioned

• Therapeutic HSV-2 vaccine (new formulation)

Snippet

Sponsor: Genocea Biosciences, Inc. | Conditions: Genital Herpes Simplex Type 2 | Phase 2 | Status: COMPLETED